Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.65M | $12.74M | -87.05% |
Operating Income | $-138.89M | $-95.06M | -46.12% |
Net Income | $-67.61M | $-40.29M | -67.80% |
EPS (Basic) | $-1.58 | $-1.27 | -24.41% |
EPS (Diluted) | $-1.58 | $-1.27 | -24.41% |
R&D Expense | $103M | $67.58M | +52.40% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $384.8M | $541.95M | -29.00% |
Current Assets | $286.35M | $440.98M | -35.06% |
Total Liabilities | $152.79M | $142.04M | +7.57% |
Current Liabilities | $74.31M | $54.51M | +36.31% |
Stockholders' Equity | $232.01M | $399.92M | -41.99% |
Cash & Equivalents | $64.44M | $220.82M | -70.82% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-106.93M | $-74.48M | -43.58% |
Investing Cash Flow | $47.21M | $36.25M | +30.24% |
Financing Cash Flow | $514,000 | $117.53M | -99.56% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -8422.9% | -746.2% | -7676.62% |
Net Margin | -4099.9% | — | — |
ROE | -29.1% | — | — |
ROA | -17.6% | — | — |
Current Ratio | $3.854 | — | — |
Debt to Equity | $0.659 | — | — |
Other companies in Biotechnology